Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1361 of 6351
-
New drug senaparib tested in Real-World ovarian cancer study
Disease control Not yet recruitingOvarian cancer is one of the most fatal malignant tumors that threaten women's health. The incidence rate is the third place among the female reproductive system malignant tumors, and the mortality rate ranks the first in gynecologic malignancies, the majority of patients have ad…
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a simple food supplement tame ulcerative colitis?
Disease control Recruiting nowThis Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a once-daily oral microbiome-targeted food supplement compared with matching placebo in adults with mild-to-moderate, objectively active ulcerative colitis. The …
Sponsor: ENBIOSIS BIOTECHNOLOGIES • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Freezing tumors before chemo: new hope for esophageal cancer?
Disease control Recruiting nowThis research study is for people who have locally advanced esophageal adenocarcinoma and are expected to receive chemotherapy. The purpose of this study is to compare the effectiveness of Liquid Nitrogen Spray Cryotherapy (LNSC) in addition to chemotherapy versus chemotherapy al…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could removing preservatives from glaucoma drops save Patients' eyes?
Disease control OngoingThe primary objective of this study is to evaluate the ocular surface safety of an ophthalmic solution indicated for the management of glaucoma, containing the active ingredients dorzolamide, timolol, and brimonidine, in patients diagnosed with primary open-angle glaucoma. The mo…
Phase 4 • Sponsor: Tecnoquimicas • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New triple therapy takes on tough colorectal cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn whether the combination of balstilimab, botensilimab, and agenT-797 is safe and effective in treating adults with previously treated metastatic colorectal cancer that is microsatellite stable (pMMR) and has spread to the liver. The mai…
Phase 2 • Sponsor: Darren Sigal, MD • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Not yet recruitingAssess the efficacy and safety of glofitamab in combination with selinexor for the treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) in patients who have received at least two prior lines of systemic therapy.
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kidney cancer patients with bone spread: drug combo trial launches
Disease control Recruiting nowThis is a single-institution, phase 2 trial of zanzalintinib plus investigator-choice bone-strengthening agent in patients with metastatic renal cell carcinoma (RCC) with bone metastases whose disease has advanced on 1-3 prior lines of therapy, including at least one immune oncol…
Phase 2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Slim down without sacrificing muscle? a protein supplement may help
Prevention OngoingThe objective of this study is to evaluate whether the supplement, combined with resistance training, prevents muscle mass loss during weight loss. The treatment will last four months and include clinical assessments, proper nutrition, and physical activity..
Sponsor: Althaia S.A Industria Farmaceutica • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Skin cells could help heal torn shoulder tendons
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy and safety of allogeneic dermal fibroblasts (TPX-115) compared to placebo in patients with Partial-Thickness Rotator Cuff Tear(PTRCT). Primary endpoint is to evaluate the efficacy of TPX-115 compared to placebo, as measured by i…
Phase 2 • Sponsor: Tego Science, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to ease fatigue in rare mitochondrial disease
Disease control Not yet recruitingThe purpose of this study is to investigate if the study medicine, KL1333, is safe, well-tolerated and effective long-term in improving the symptoms of fatigue and impacts on daily living and functional capacity (physical abilities) in people with PMD.
Phase 2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug aims to stop kidney transplant rejection
Disease control Recruiting nowThe goal of the global Phase 1/2 clinical trial is to evaluate whether CID-103, a novel anti-CD38 monoclonal antibody, is safe and effective in adults with with active and chronic active renal allograft antibody mediated rejection (ABMR). The main questions the study aims to answ…
Phase 1/2 • Sponsor: CASI pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a scan replace surgery for breast cancer staging?
Diagnosis Recruiting nowStudy hypothesis is that combining the advantages of hybrid PET/MRI and the high sensitivity/specificity of 16-alpha-18F-fluoro-17-beta-estradiol(FES), a radiolabeled form of estrogen binding to functionally active ER, the investigators could obtain a reliable, non-invasive, oper…
Phase 2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New obesity drug trial aims for 25% weight loss with gentler dosing
Disease control Recruiting nowThe purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Chilled water may curb pancreatitis risk after Bile-Duct procedure
Prevention Recruiting nowThe standard prophylaxis for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is performed with rectal non-steroidal anti-inflammatory drugs (NSAIDs). A recent Japanese study demonstrated the efficacy of irrigating the periampullary region with ice water, ho…
Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
New drug cocktail aims to shrink NF1 tumors
Disease control Recruiting nowBased on the clinical activity of both selumetinib and cabozantinib as monotherapies in clinical trials, the demonstrated activity of these agents in reduced doses in preclinical studies, and the non-overlapping toxicity profiles, the study will assess the tolerability and effica…
Phase 1 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Digital brain training may ease 'chemo brain' — a trial puts it to the test
Symptom relief Recruiting nowThe aim of this study is to evaluate the usability and effectiveness of two professionally supervised home-based cognitive training interventions as part of an early rehabilitation protocol for cancer-related cognitive impairment. Participants will be randomized to one of the tw…
Sponsor: Biogipuzkoa Health Research Institute • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
A new nerve block could transform Kids' Post-Surgery pain relief
Symptom relief Recruiting nowThis study aims to compare the analgesic efficacy of ultrasound-guided erector spinae plane block and caudal block for postoperative pain management in pediatric patients undergoing orchiopexy. Postoperative pain scores, time to first rescue analgesic requirement, total analgesic…
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Cast vs. boot: which heals a Child's ankle fracture best?
Disease control Recruiting nowThis is a randomized control trial of pediatric patients with acute lateral ankle avulsion fractures. Patients will be randomized into two groups: Standard of care treatment which includes booting with early range of motion and gradual weening from the boot and a Test treatment w…
Sponsor: Texas Scottish Rite Hospital for Children • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Lifeline for cancer patients: rollover study extends access to targeted drug opnurasib
Disease control Recruiting nowThe purpose of this study is to allow continued access to opnurasib (JDQ443) to participants who are benefitting from treatment with opnurasib as a single agent or in combination with other study treatments in pre-defined Novartis-sponsored opnurasib studies and to continue to as…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
New PET tracer could sharpen prostate cancer detection
Diagnosis Recruiting nowPrimary Objective: To evaluate the safety and tolerability of PET imaging following a single intravenous infusion of \[⁶⁸Ga\]Ga-ELI421 injection in patients with prostate cancer. Secondary Objectives: To evaluate the biodistribution characteristics of \[⁶⁸Ga\]Ga-ELI421 injecti…
Phase 1/2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC